RGLS
Regulus Therapeutics
RGLS
RGLS
Delisted
RGLS was delisted on the 24th of June, 2025.
58 hedge funds and large institutions have $33.1M invested in Regulus Therapeutics in 2017 Q1 according to their latest regulatory filings, with 9 funds opening new positions, 20 increasing their positions, 19 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
40% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 15
87% less call options, than puts
Call options by funds: $14K | Put options by funds: $107K
Holders
58
Holding in Top 10
–
Calls
$14K
Puts
$107K
Top Buyers
1 | +$3.5M | |
2 | +$2.49M | |
3 | +$1.39M | |
4 |
BI
BVF Inc
San Francisco,
California
|
+$1.03M |
5 |
SDIC
South Dakota Investment Council
Sioux Falls,
South Dakota
|
+$307K |
Top Sellers
1 | -$10.5M | |
2 | -$2.4M | |
3 | -$847K | |
4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$357K |
5 |
Renaissance Technologies
New York
|
-$334K |